MAIA Biotechnology, Inc.
4444 West Lake Street, Suite 1700
Chicago, IL 60606
April 21, 2023
VIA EDGAR & TELECOPY
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
Washington, D.C. 20549
Attention: Jimmy McNamara
|
RE: |
MAIA Biotechnology, Inc. (the “Company”) |
|
|
Registration Statement on Form S-1 (File No. 333-269606) (the “Registration Statement”) Withdrawal Request for Acceleration of Effective Date
|
Ladies and Gentlemen:
Reference is made to the Company’s letter, filed as correspondence via EDGAR on April 18, 2023, in which the Company requested acceleration of effectiveness of the Registration Statement. The Company hereby formally withdraws its request for acceleration of the effective date pursuant to the prior letter.
|
|
Very truly yours, |
||
|
|
|
||
|
|
By: |
/s/ Vlad Vitoc |
|
|
|
|
Name: |
Vlad Vitoc |
|
|
|
Title: |
Chief Executive Officer |
|
cc: |
Angela Dowd, Esq., Loeb & Loeb LLP
|